Alloplex Biotherapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $20.7M

  • Investors
  • 4

Alloplex Biotherapeutics General Information

Description

Operator of a cellular therapy company intended to develop effective anti-tumor vaccines. The company has developed a differentiated, non-engineered, tumor-agnostic cellular therapy platform with broad anti-tumor activity, enabling physicians to treat cancer in an improved manner.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 300 Trade Center
  • Suite 6580
  • Woburn, MA 01801
  • United States
+1 (857)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 300 Trade Center
  • Suite 6580
  • Woburn, MA 01801
  • United States
+1 (857)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Alloplex Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 09-Feb-2023 $20.7M Completed Clinical Trials - Phase 2
1. Angel (individual) 24-Jul-2019 Completed Clinical Trials - Phase 1
To view Alloplex Biotherapeutics’s complete valuation and funding history, request access »

Alloplex Biotherapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Alloplex Biotherapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Alloplex Biotherapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a cellular therapy company intended to develop effective anti-tumor vaccines. The company has developed a di
Drug Discovery
Woburn, MA
6 As of 2024

San Carlos, CA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Alloplex Biotherapeutics Competitors (5)

One of Alloplex Biotherapeutics’s 5 competitors is Iovance Biotherapeutics, a Corporation company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Iovance Biotherapeutics Corporation San Carlos, CA
Adicet Bio Formerly VC-backed Boston, MA
Fate Therapeutics Formerly VC-backed San Diego, CA
Allogene Therapeutics Formerly VC-backed South San Francisco, CA
MiNK Therapeutics Corporation New York, NY
You’re viewing 5 of 5 competitors. Get the full list »

Alloplex Biotherapeutics Patents

Alloplex Biotherapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2020453180-A1 Allogeneic tumor cell vaccine Pending 11-Jun-2020
CA-3182206-A1 Allogeneic tumor cell vaccine Pending 11-Jun-2020
EP-4164750-A1 Allogeneic tumor cell vaccine Pending 11-Jun-2020
EP-4164750-A4 Allogeneic tumor cell vaccine Pending 11-Jun-2020
JP-2025163127-A Allogeneic tumor cell vaccine Pending 11-Jun-2020 A61K40/34
To view Alloplex Biotherapeutics’s complete patent history, request access »

Alloplex Biotherapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Alloplex Biotherapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Daewoong Pharmaceutical Corporation Minority
Hanall Biopharma Corporation Minority
Keiretsu Forum Angel Group Minority
Wells Investment Growth/Expansion Minority
To view Alloplex Biotherapeutics’s complete investors history, request access »

Alloplex Biotherapeutics FAQs

  • When was Alloplex Biotherapeutics founded?

    Alloplex Biotherapeutics was founded in 2016.

  • Where is Alloplex Biotherapeutics headquartered?

    Alloplex Biotherapeutics is headquartered in Woburn, MA.

  • What is the size of Alloplex Biotherapeutics?

    Alloplex Biotherapeutics has 6 total employees.

  • What industry is Alloplex Biotherapeutics in?

    Alloplex Biotherapeutics’s primary industry is Drug Discovery.

  • Is Alloplex Biotherapeutics a private or public company?

    Alloplex Biotherapeutics is a Private company.

  • What is the current valuation of Alloplex Biotherapeutics?

    The current valuation of Alloplex Biotherapeutics is .

  • What is Alloplex Biotherapeutics’s current revenue?

    The current revenue for Alloplex Biotherapeutics is .

  • How much funding has Alloplex Biotherapeutics raised over time?

    Alloplex Biotherapeutics has raised $21.1M.

  • Who are Alloplex Biotherapeutics’s investors?

    Daewoong Pharmaceutical, Hanall Biopharma, Keiretsu Forum, and Wells Investment have invested in Alloplex Biotherapeutics.

  • Who are Alloplex Biotherapeutics’s competitors?

    Iovance Biotherapeutics, Adicet Bio, Fate Therapeutics, Allogene Therapeutics, and MiNK Therapeutics are competitors of Alloplex Biotherapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process